Trinity Biotech (TRIB) Institutional Ownership $0.63 -0.04 (-5.57%) Closing price 05/28/2025 03:57 PM EasternExtended Trading$0.67 +0.04 (+6.13%) As of 05/28/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Trinity Biotech (NASDAQ:TRIB)CurrentInstitutional OwnershipPercentage78.97%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$45.24KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$147.85K Get TRIB Insider Trade Alerts Want to know when executives and insiders are buying or selling Trinity Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRIB Institutional Buying and Selling by Quarter Trinity Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC189,053$166K0.0%-24.4%1.047% 1/23/2025 Hunter Associates Investment Management LLC378,590$334K0.1%+5.2%0.000% 10/24/2024 Hunter Associates Investment Management LLC359,810$390K0.1%+7.8%4.722% 8/6/2024 Acadian Asset Management LLC72,110$149K0.0%-38.0%0.946% 5/17/2024 Whitefort Capital Management LP81,902$167K0.1%-80.0%1.075% 5/10/2024 Acadian Asset Management LLC116,276$237K0.0%-83.0%1.526% 5/2/2024 Hunter Associates Investment Management LLC317,810$644K0.1%-80.5%4.171% 1/31/2024 Hunter Associates Investment Management LLC1,625,900$700K0.1%-6.1%4.266% 8/15/2023 Stonehill Capital Management LLC1,512,975$1.44M0.9%-4.7%3.970% 8/7/2023 Acadian Asset Management LLC727,954$701K0.0%-2.0%1.910% Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/3/2023 Hunter Associates Investment Management LLC1,724,000$1.66M0.3%-2.9%4.524% 7/13/2023 Cambridge Investment Research Advisors Inc.111,400$106K0.0%N/A0.292% 5/12/2023 Aristides Capital LLC162,317$153K0.1%-26.1%0.426% 5/2/2023 Hunter Associates Investment Management LLC1,775,100$1.68M0.4%-2.7%4.658% 2/1/2023 Hunter Associates Investment Management LLC1,823,633$1.81M0.4%+1.5%4.785% 11/2/2022 Hunter Associates Investment Management LLC1,797,190$1.91M0.5%-0.6%4.716% 8/10/2022 Hunter Associates Investment Management LLC1,808,533$2.20M0.5%-25.0%6.719% 5/12/2022 Acadian Asset Management LLC815,461$862K0.0%-3.3%3.901% 5/11/2022 Highbridge Capital Management LLC1,151,610$1.22M0.0%N/A5.510% 4/26/2022 Hunter Associates Investment Management LLC2,412,116$2.56M0.8%+5.5%11.540% 2/14/2022 Stonehill Capital Management LLC219,946$315K0.1%-55.0%1.052% 2/14/2022 Whitefort Capital Management LP35,068$50K0.0%N/A0.168% 2/10/2022 Acadian Asset Management LLC843,523$1.20M0.0%-1.4%4.036% 2/4/2022 Envestnet Asset Management Inc.110,901$159K0.0%N/A0.531% 1/27/2022 Hunter Associates Investment Management LLC2,286,150$3.27M0.9%+9.1%10.937% 11/18/2021Wealthsource Partners LLC30,200$65K0.0%N/A0.144% 11/15/2021 Marshall Wace LLP34,703$75K0.0%-37.5%0.166% 11/15/2021 Hunter Associates Investment Management LLC2,095,900$4.53M1.5%+2.0%10.027% 11/12/2021 Renaissance Technologies LLC1,746,841$3.77M0.0%-5.6%8.357% 10/28/2021 Navellier & Associates Inc.15,485$33K0.0%-84.6%0.074% 8/25/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/16/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/13/2021 Renaissance Technologies LLC1,850,082$5.44M0.0%+0.3%8.851% 8/13/2021 LPL Financial LLC60,073$177K0.0%+171.5%0.287% 8/9/2021 Navellier & Associates Inc100,611$296K0.0%+23.1%0.481% 5/19/2021 Squarepoint Ops LLC36,450$137K0.0%N/A0.174% 5/18/2021 Millennium Management LLC59,019$222K0.0%-39.5%0.282% 5/17/2021 HRT Financial LP14,100$53K0.0%N/A0.067% 5/13/2021 Renaissance Technologies LLC1,844,963$6.94M0.0%-3.2%8.827% 5/12/2021 Navellier & Associates Inc81,746$307K0.1%+25.8%0.391% Is President Trump Lying To You With This? (Ad)President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.Protect your IRA—Trump’s warning was real5/11/2021 Acadian Asset Management LLC753,293$2.83M0.0%+20.6%3.604% (Data available from 1/1/2016 forward) TRIB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRIB shares? During the previous two years, the following institutional investors and hedge funds held shares of Trinity Biotech shares: Stonehill Capital Management LLC ($1.44M), Hunter Associates Investment Management LLC ($334K), Whitefort Capital Management LP ($167K), Renaissance Technologies LLC ($166K), and Acadian Asset Management LLC ($149K), Cambridge Investment Research Advisors Inc. ($106K).Learn more on TRIB's institutional investors. What percentage of Trinity Biotech stock is owned by institutional investors? 78.97% of Trinity Biotech stock is owned by institutional investors. Learn more on TRIB's institutional investor holdings. Which institutional investors have been buying Trinity Biotech stock? The following institutional investors have purchased Trinity Biotech stock in the last 24 months: Cambridge Investment Research Advisors Inc. ($111.40K), and Hunter Associates Investment Management LLC ($44.88K). How much institutional buying is happening at Trinity Biotech? Institutional investors have bought a total of 156,280 shares in the last 24 months. This purchase volume represents approximately $575.00K in transactions. Which Trinity Biotech major shareholders have been selling company stock? The following institutional investors have sold Trinity Biotech stock in the last 24 months: Hunter Associates Investment Management LLC ($1.47M), Acadian Asset Management LLC ($627.37K), Whitefort Capital Management LP ($327.62K), Stonehill Capital Management LLC ($75K), and Renaissance Technologies LLC ($61.10K). How much institutional selling is happening at Trinity Biotech? Institutional investors have sold a total of 2,556,772 shares in the last 24 months. This volume of shares sold represents approximately $5.54M in transactions. Related Companies Repare Therapeutics Institutional Ownership Immix Biopharma Institutional Ownership Gain Therapeutics Institutional Ownership Outlook Therapeutics Institutional Ownership Biomea Fusion Institutional Ownership Actinium Pharmaceuticals Institutional Ownership Immuneering Institutional Ownership OKYO Pharma Institutional Ownership Ikena Oncology Institutional Ownership Cue Biopharma Institutional Ownership This page (NASDAQ:TRIB) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.